Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hong kong trial tests 'Through the Gate' program to cut reoffending

NCT ID NCT07593534

Disease control Sponsor: The University of Hong Kong Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a social work program called Project ReBond for people serving their first or second prison sentence in Hong Kong. The program includes workshops and counseling before release, plus support like job help and mentoring after release. Researchers will track 300 participants for 13 months to see if the program reduces reoffending compared to standard services.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Desistance-based social work intervention
What this could lead to
If successful, this program could provide an effective way to reduce reoffending and support former prisoners in rebuilding their lives.
What could go wrong
This is a relatively small trial (300 people) in one city, so results may not apply elsewhere. The study relies on self-reported reoffending, which may not be fully accurate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Hong Kong residents; * Aged 18 years or above and capable of providing informed consent * Serving a maximum of two sentences (including the current one) across any level or type of correctional facility * The current sentence lasts between 3 and 12 months. Exclusion Criteria: * Physical conditions that preclude participation in at least 80% (six or seven sessions) of the Stage 1 in-prison workshops * Psychological conditions (e.g. bipolar disorder or schizophrenia) that preclude participation in at least 80% (six or seven sessions) of the Stage 1 in-prison workshops * Medical appointments that preclude participation in at least 80% (six or seven sessions) of the Stage 1 in-prison workshops * Inadequate Cantonese or English proficiency that prevent the individual from providing informed consent and participating in the Stage 1 group workshops * Cognitive impairments that prevent the individual from providing informed consent and participating in the Stage 1 group workshops * A history or high risk of inflicting physical harm on other participants, clinicians, or CSD staff

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Recidivism are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Recidivism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Recidivism

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The University of Hong Kong

    RECRUITING

    Hong Kong, Hong Kong Island, 000, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.